Mediwound - submitted biologics license application to the fda for nexobrid for thermal burns treatment

Mediwound announces submission of biologics license application to the u.s. fda for nexobrid for the treatment of severe thermal burns.

MDWD Ratings Summary

MDWD Quant Ranking